References
- Ariëns E. J. Implications of the neglect of stereochemistry in pharmacokinetics and clinical pharmacology. Drug Intelligence and Clinical Pharmacy 1987; 21: 827–829
- Buckingham R. E., Clapham J. C., Coldwell M. C., Hamilton T. C., Howlett D. R. Stereospecific mechanism of action of the novel anti-hypertensive agent, BRL 34915. British Journal of Pharmacology 1986; 87: 78P
- De Camp W. H. The FDA Perspective on the Development of Stereoisomers. Chirality 1989; 1: 2–6
- Gill T. S., Allen G. D., Davies B. E. A stereospecific GC-MS assay for cromakalim enantiomers in plasma and urine. British Journal of Clinical Pharmacology 1988; 26: 227P
- Shaw W. A., Harlan W. R., Bennett A. An improved method for counting radioisotopes absorbed on silica gel. Analytical Biochemistry 1971; 43: 119–122
- Tomlinson P. W., Jeffery D. J., Filer C. W. A novel technique for assessment of biliary secretion and enterohepatic circulation in the unrestrained conscious rat. Xenobiotica 1981; 11(12)863–870
- Tucker G. T., Lennard M. S. Enantiomer specific pharmacokinetics. Pharmacology and Therapeutics 1990; 45(3)309–329